BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 25, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 2, 2004
View Archived Issues
Palatin Raises $22.7M For Drug Trials Via Stock, Warrants Sale
Read More
Inspire Will Conduct Additional Trial For More Diquafosol Data
Read More
Wall Street's Gilead Anxiety Unfounded, Analyst Believes
Read More
Correction
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Eyetech Stock Surges With Biotech's First IPO Of 2004
Earning the honor of first biotechnology company to conduct an IPO this year, Eyetech Pharmaceuticals Inc. raised $136.5 million and watched its stock skyrocket on Friday, trading up 54.3 percent from its opening price. (BioWorld Today)
Read More
